
- 368 pages
- English
- PDF
- Available on iOS & Android
Emerging Protein Biotherapeutics
About this book
Given the speed at which antibody therapy is becoming readily accepted, a comprehensive industry guide is sorely needed. Written by leading international authorities, this book maintains an overall emphasis on various therapeutic approaches and applications and provides critical discussions on the most significant areas of research in biologics. It focuses on the applications of protein biologics in autoimmunity and inflammation, hematological malignancies, and solid tumors. Each chapter clearly presents the most informative and contemporary account of its subject available, making this an unrivaled reference source beneficial to those in both academia and biotechnology industries.
Tools to learn more effectively

Saving Books

Keyword Search

Annotating Text

Listen to it instead
Information
Table of contents
- Front cover
- Contents
- Preface
- About the Editor
- Contributors
- Section I: Introduction
- Chapter 1. Overview of Antibody- Based Therapeutics: Present and Future Promise
- Section II: Biologics for Autoimmunity and Imflammation
- Chapter 2. Biologic Therapies for Multiple Sclerosis
- Chapter 3. Biologic Therapies in Rheumatoid Arthritis
- Chapter 4. Biologic Therapies in Systemic Lupus Erythematosus
- Chapter 5. Biologic Therapies for Inflammatory Bowel Disease
- Chapter 6. Biologic Therapies for Psoriasis
- Chapter 7. TNFα Inhibitors: Emerging Biologic Therapies for the Treatment of Asthma
- Chapter 8. Protein-Based Therapies in Experimental and Clinical Transplantation
- Chapter 9. Biologic Therapies for Type 1 Diabetes
- Section III: Biologics for Hematological Malignancies
- Chapter 10. Biologic Therapies for Acute Myeloid Leukemia/ Myelodysplastic Syndrome
- Chapter 11. Biologic Therapies for Non-Hodgkin Lymphoma and Hodgkin Disease
- Chapter 12. Biologic Therapies for Chronic Lymphocytic Leukemia
- Chapter 13. Biologic Therapies for Multiple Myeloma and Plasma Cell Disorders
- Section IV: Development of Biotherapies for Solid Tumors
- Chapter 14. Antibody-Based Therapies for Carcinomas
- Chapter 15. Role of Vascular Targeting Agents in the Treatment of Solid Tumors: Current and Future Developments
- Chapter 16. Recent Advancements in the Use of Antibody– Drug Conjugates for Cancer Therapy
- Index
- Back cover
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app